Nursing support using mobile health information for breast cancer patients during chemotherapy
Effects of a Nursing-led Communication Support Program Using Mobile Health Information on Physical and Mental Status in Breast Cancer Patients Undergoing Concurrent Chemotherapy: a Randomized Controlled Trial
This study tests whether a mobile health support program from nurses can help breast cancer patients feel better physically and mentally while they go through chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | National Defense Medical Center, Taiwan Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06949046 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the impact of a nursing-led communication support program that utilizes mobile health information on the physical and mental well-being of breast cancer patients undergoing initial chemotherapy. By integrating mobile technology with nursing support, the study seeks to address common side effects of chemotherapy, such as anxiety, depression, and sleep disorders. The approach focuses on enhancing patient communication and providing timely information to improve overall quality of life during treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are women diagnosed with early-stage breast cancer who are starting their first course of chemotherapy.
Not a fit: Patients whose cancer has recurred without undergoing the first course of chemotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the mental and physical health outcomes of breast cancer patients undergoing chemotherapy.
How similar studies have performed: Other studies have shown promising results with similar nursing-led interventions and mobile health approaches, indicating potential for success in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: breast cancer initial chemotherapy Exclusion Criteria: Patients whose cancer has recurred without undergoing the first course of chemotherapy
Where this trial is running
Taipei
- Tri-Service General Hospital — Taipei, Taiwan (Recruiting)
Study contacts
- Study coordinator: Man Mei Postdoctoral researcher
- Email: summermei5779@gmail.com
- Phone: 886975801033
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.